Literature DB >> 14675740

Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.

Tiziana Zalla1, Cécile Joyce, Andrei Szöke, Franck Schürhoff, Bernard Pillon, Odile Komano, Fernando Perez-Diaz, Frank Bellivier, Caroline Alter, Bruno Dubois, Frédéric Rouillon, Olivier Houde, Marion Leboyer.   

Abstract

Attentional and executive impairments have been found both in patients with schizophrenia and in their unaffected first-degree relatives, suggesting that they might be considered as familial vulnerability markers. Several studies have shown that the performance of bipolar patients does not significantly differ from that of schizophrenic patients, so that executive and attentional deficits might not be specific to schizophrenia. In the present study, we aimed to identify executive dysfunctions in schizophrenia and bipolar disorder that might be vulnerability trait markers specific to one or common to both of these diseases. We assessed cognitive performance of euthymic bipolar and schizophrenic patients, their unaffected first-degree relatives and a healthy control group, using neuropsychological tasks to test different components of executive function: the Verbal Fluency Test, the Stroop Word Colour Test, the Wisconsin Card Sorting Test and the Trail Making Test. The two groups of patients and their unaffected relatives demonstrated disproportionately increased slowness on the Stroop test in comparison to the normal healthy group. Patients with schizophrenia performed poorly on all the tests in comparison to the normal healthy subjects, while no other impairment was observed in the bipolar patients and in the relatives of schizophrenic and bipolar patients. Enhanced susceptibility to interference and reduced inhibition could be transnosographical markers for a shared familial vulnerability common to schizophrenia and bipolar disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675740     DOI: 10.1016/s0165-1781(03)00252-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  52 in total

Review 1.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction.

Authors:  Chiang-shan Ray Li; Rajita Sinha
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

3.  An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder.

Authors:  Heidi W Thermenos; Jill M Goldstein; Snezana M Milanovic; Susan Whitfield-Gabrieli; Nikos Makris; Peter Laviolette; Jennifer K Koch; Stephen V Faraone; Ming T Tsuang; Stephen L Buka; Larry J Seidman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

4.  Cognitive deficits in first-degree relatives of bipolar patients: the use of homogeneous subgroups in the search of cognitive endophenotypes.

Authors:  Julia Volkert; J Haubner; J Kazmaier; F Glaser; J Kopf; S Kittel-Schneider; A Reif
Journal:  J Neural Transm (Vienna)       Date:  2016-06-08       Impact factor: 3.575

Review 5.  Brain functional domains inform therapeutic interventions in attention-deficit/hyperactivity disorder and pediatric bipolar disorder.

Authors:  Alessandra M Passarotti; Mani N Pavuluri
Journal:  Expert Rev Neurother       Date:  2011-06       Impact factor: 4.618

6.  Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.

Authors:  Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

7.  Neurocognitive impairment in unaffected siblings of youth with bipolar disorder.

Authors:  A E Doyle; J Wozniak; T E Wilens; A Henin; L J Seidman; C Petty; R Fried; L M Gross; S V Faraone; J Biederman
Journal:  Psychol Med       Date:  2008-12-11       Impact factor: 7.723

8.  Neurological soft signs and cognitive functions: Amongst euthymic bipolar I disorder cases, non-affected first degree relatives and healthy controls.

Authors:  Srikant Sharma; Triptish Bhatia; Sati Mazumdar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-04-23

Review 9.  Pediatric bipolar disorder: evidence for prodromal states and early markers.

Authors:  Joan L Luby; Neha Navsaria
Journal:  J Child Psychol Psychiatry       Date:  2010-01-18       Impact factor: 8.982

10.  Cognitive deficits in psychiatric disorders: Current status.

Authors:  J K Trivedi
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.